-
1
-
-
0035206979
-
PAD awareness, risk, and treatment: new resources for survival—the USA PARTNERS program
-
1 Hirsch, A.T., Hiatt, W.R., PAD awareness, risk, and treatment: new resources for survival—the USA PARTNERS program. Vasc Med 6 (2001), 9–12.
-
(2001)
Vasc Med
, vol.6
, pp. 9-12
-
-
Hirsch, A.T.1
Hiatt, W.R.2
-
2
-
-
0037471546
-
Critical issues in peripheral arterial disease detection and management: a call to action
-
2 Belch, J.J., Topol, E.J., Agnelli, G., et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 163 (2003), 884–892.
-
(2003)
Arch Intern Med
, vol.163
, pp. 884-892
-
-
Belch, J.J.1
Topol, E.J.2
Agnelli, G.3
-
3
-
-
68349161985
-
One-year costs in patients with a history of or at risk for atherothrombosis in the United States
-
3 Mahoney, E.M., Wang, K., Cohen, D.J., et al. One-year costs in patients with a history of or at risk for atherothrombosis in the United States. Circ Cardiovasc Qual Outcomes 1 (2008), 38–45.
-
(2008)
Circ Cardiovasc Qual Outcomes
, vol.1
, pp. 38-45
-
-
Mahoney, E.M.1
Wang, K.2
Cohen, D.J.3
-
4
-
-
33846497950
-
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
-
4 Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., Fowkes, F.G., Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45:Suppl S (2007), S5–S67.
-
(2007)
J Vasc Surg
, vol.45
, pp. S5-S67
-
-
Norgren, L.1
Hiatt, W.R.2
Dormandy, J.A.3
Nehler, M.R.4
Harris, K.A.5
Fowkes, F.G.6
-
5
-
-
78650238256
-
Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States
-
5 Mahoney, E.M., Wang, K., Keo, H.H., et al. Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes 3 (2010), 642–651.
-
(2010)
Circ Cardiovasc Qual Outcomes
, vol.3
, pp. 642-651
-
-
Mahoney, E.M.1
Wang, K.2
Keo, H.H.3
-
6
-
-
84055172778
-
The treatment of femoropopliteal in-stent restenosis: back to the future
-
6 Laird, J.R., Yeo, K.K., The treatment of femoropopliteal in-stent restenosis: back to the future. J Am Coll Cardiol 59 (2012), 24–25.
-
(2012)
J Am Coll Cardiol
, vol.59
, pp. 24-25
-
-
Laird, J.R.1
Yeo, K.K.2
-
7
-
-
11844296114
-
Prevalence and clinical impact of stent fractures after femoropopliteal stenting
-
7 Scheinert, D., Scheinert, S., Sax, J., et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45 (2005), 312–315.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 312-315
-
-
Scheinert, D.1
Scheinert, S.2
Sax, J.3
-
8
-
-
84923684095
-
Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial
-
8 Tepe, G., Laird, J., Schneider, P., et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 131 (2015), 495–502.
-
(2015)
Circulation
, vol.131
, pp. 495-502
-
-
Tepe, G.1
Laird, J.2
Schneider, P.3
-
9
-
-
84958961875
-
Sustained durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA
-
9 Laird, J.R., Schneider, P.A., Tepe, G., et al. Sustained durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA. J Am Coll Cardiol 66 (2015), 2329–2338.
-
(2015)
J Am Coll Cardiol
, vol.66
, pp. 2329-2338
-
-
Laird, J.R.1
Schneider, P.A.2
Tepe, G.3
-
10
-
-
84936746214
-
Trial of a paclitaxel-coated balloon for femoropopliteal artery disease
-
10 Rosenfield, K., Jaff, M.R., White, C.J., et al. Trial of a paclitaxel-coated balloon for femoropopliteal artery disease. N Engl J Med 373 (2015), 145–153.
-
(2015)
N Engl J Med
, vol.373
, pp. 145-153
-
-
Rosenfield, K.1
Jaff, M.R.2
White, C.J.3
-
11
-
-
84880119627
-
Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease
-
11 Kearns, B.C., Michaels, J.A., Stevenson, M.D., Thomas, S.M., Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease. Br J Surg 100 (2013), 1180–1188.
-
(2013)
Br J Surg
, vol.100
, pp. 1180-1188
-
-
Kearns, B.C.1
Michaels, J.A.2
Stevenson, M.D.3
Thomas, S.M.4
-
12
-
-
84908196442
-
Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany
-
12 Pietzsch, J.B., Geisler, B.P., Garner, A.M., Zeller, T., Jaff, M.R., Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany. Catheter Cardiovasc Interv 84 (2014), 546–554.
-
(2014)
Catheter Cardiovasc Interv
, vol.84
, pp. 546-554
-
-
Pietzsch, J.B.1
Geisler, B.P.2
Garner, A.M.3
Zeller, T.4
Jaff, M.R.5
-
13
-
-
14844319324
-
US valuation of the EQ-5D health states: development and testing of the D1 valuation model
-
13 Shaw, J.W., Johnson, J.A., Coons, S.J., US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care 43 (2005), 203–220.
-
(2005)
Med Care
, vol.43
, pp. 203-220
-
-
Shaw, J.W.1
Johnson, J.A.2
Coons, S.J.3
-
14
-
-
0028790206
-
In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial
-
14 Cohen, D.J., Krumholz, H.M., Sukin, C.A., et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Circulation 92 (1995), 2480–2487.
-
(1995)
Circulation
, vol.92
, pp. 2480-2487
-
-
Cohen, D.J.1
Krumholz, H.M.2
Sukin, C.A.3
-
15
-
-
3543064732
-
Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial
-
15 Cohen, D.J., Bakhai, A., Shi, C., et al. Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses: results from the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) trial. Circulation 110 (2004), 508–514.
-
(2004)
Circulation
, vol.110
, pp. 508-514
-
-
Cohen, D.J.1
Bakhai, A.2
Shi, C.3
-
16
-
-
0037348974
-
Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials
-
16 Taira, D.A., Seto, T.B., Siegrist, R., Cosgrove, R., Berezin, R., Cohen, D.J., Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J 145 (2003), 452–458.
-
(2003)
Am Heart J
, vol.145
, pp. 452-458
-
-
Taira, D.A.1
Seto, T.B.2
Siegrist, R.3
Cosgrove, R.4
Berezin, R.5
Cohen, D.J.6
-
17
-
-
84892987217
-
The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty
-
17 Scheinert, D., Duda, S., Zeller, T., et al. The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. J Am Coll Cardiol Intv 7 (2014), 10–19.
-
(2014)
J Am Coll Cardiol Intv
, vol.7
, pp. 10-19
-
-
Scheinert, D.1
Duda, S.2
Zeller, T.3
-
18
-
-
84899512831
-
Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes
-
18 Mueller, T., Hinterreiter, F., Luft, C., Poelz, W., Haltmayer, M., Dieplinger, B., Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg 59 (2014), 1291–1299.
-
(2014)
J Vasc Surg
, vol.59
, pp. 1291-1299
-
-
Mueller, T.1
Hinterreiter, F.2
Luft, C.3
Poelz, W.4
Haltmayer, M.5
Dieplinger, B.6
-
19
-
-
0031900689
-
Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis
-
19 Stinnett, A.A., Mullahy, J., Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 18 (1998), S68–S80.
-
(1998)
Med Decis Making
, vol.18
, pp. S68-S80
-
-
Stinnett, A.A.1
Mullahy, J.2
-
20
-
-
84901630147
-
ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines
-
20 Anderson, J.L., Heidenreich, P.A., Barnett, P.G., et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2304–2322.
-
(2014)
J Am Coll Cardiol
, vol.63
, pp. 2304-2322
-
-
Anderson, J.L.1
Heidenreich, P.A.2
Barnett, P.G.3
-
21
-
-
84921404014
-
Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial
-
21 Tepe, G., Schnorr, B., Albrecht, T., et al. Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. J Am Coll Cardiol Intv 8 (2015), 102–108.
-
(2015)
J Am Coll Cardiol Intv
, vol.8
, pp. 102-108
-
-
Tepe, G.1
Schnorr, B.2
Albrecht, T.3
|